VUB Techtransfer

Through our scientific research and associated innovations, we aim to make a positive contribution to society. Many of our successful research projects lead to spin-offs and licensing opportunities. Below, you can discover which spin-offs and licensing opportunities have emerged from our faculty. The full portfolio of spin-offs and licensing opportunities can be found on the VUB TechTransfer website.

Spin-offs

ABSCINT

Founded in 2021 – spin-off from the MITH research group
Develops radioactively labeled nanobodies that can detect diseases in a single scan and support therapy selection

BETA-CELL

Founded in 1998 – spin-off from the DIAB research group
Develops cell therapies that protect and restore insulin-producing cells to enable more sustainable diabetes treatment

eTheRNA

Founded in 2013 – spin-off from the LMCT research group (now TORC)
Translates mRNA research into new vaccines and immune therapies

FERTIGA

Founded in 2017 – spin-off from the FOBI research group (now GRAD)
Accelerates the path to pregnancy through a non-invasive molecular test that helps select the most viable egg cell

ISEE

Founded in 2017 – spin-off from the REGEDIM research group
Helps healthcare organizations respond quickly and effectively to incidents and crisis situations through realistic simulations and training

Lavima Fertility

Founded in 2020 – spin-off from the FOBI research group (now GRAD)
Makes fertility treatments less burdensome thanks to an innovative IVF technology that allows egg cells to mature in the lab without hormonal stimulation

Presscuff

Founded in 2023 – spin-off from the Intensive Care Unit of UZ Brussel
Innovative ventilation tube that helps prevent lung infections in patients receiving mechanical ventilation

Zebra Academy

Founded in 2016 – spin-off from the Centre for Neurosciences
Improves outcomes for stroke patients through real-time telecare in the ambulance

PRECIRIX

Founded in 2017 – spin-off from the MITH research group
Develops radioactively labeled nanobodies that rapidly and selectively target cancer cells while sparing healthy tissue

Licentie opportuniteiten

APCAD

Innovative genetic analysis method that detects the full spectrum of chromosomal abnormalities in IVF embryos

More licensing opportunities

coming soon